Machine and Deep Learning for Congenital Diaphragmatic Hernia (CLANNISH)
CLANNISH
A Machine Learning Approach to Predict Pulmonary Hypertension in Newborns With Congenital Diaphragmatic Hernia: a Pilot Study
1 other identifier
observational
50
0 countries
N/A
Brief Summary
Congenital Diaphragmatic Hernia (CDH) is characterized by an incomplete diaphragm formation, resulting in poor lung development (pulmonary hypoplasia), associated with altered vascularization of the lung (pulmonary hypertension), with respiratory and cardiovascular insufficiency at birth. Mortality and morbidity are extremely variable. Several efforts have been done to identify possible prenatal and postnatal indicators which could accurately predict patients' prognosis and to promote an individualized management. However, to date the accuracy of these factors with respect to the prediction of survival and disease severity still has limits. In the last years, there has been an impressive development of new research methodologies based on the artificial intelligence, also in the neonatal field. The Machine Learning (ML) method explores the possibility of building algorithms starting from the acquisition of relevant clinical data, and using them to make predictions or take decisions. Nevertheless, the ML method has never been applied to predict patient's outcome in newborns with CDH so far. Moreover, with the available tools, a reliable prediction on patient's risk of developing severe postnatal PH is not feasible. Our hypothesis is that the use of ML approach, based on multivariate analysis of different clinical pre- and postnatal variables, could allow the development of algorithms able to accurately predict patient's outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2012
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 20, 2020
CompletedFirst Posted
Study publicly available on registry
October 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedNovember 12, 2024
November 1, 2024
10.8 years
October 20, 2020
November 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prediction of suprasystemic pulmonary hypertension
The main objective of the study is to develop a model to identify prenatally CDH patients who will develop suprasystemic PH, assessed in the time frame from birth to 48 hours after surgery and at discharge from the NICU.
from birth to 48 hours after birth
Secondary Outcomes (4)
Prediction of death
from birth up to 24 weeks
Prediction of extracorporeal membrane oxygenation (ECMO)
from birth up to 24 weeks
Prediction of favorable response to extracorporeal membrane oxygenation (ECMO)
from birth up to 24 weeks
Prediction of favorable response to Fetoscopic Endotracheal Occlusion (FETO)
from birth up to 24 weeks
Interventions
retrospective data collection
Eligibility Criteria
Patients with CDH born between January 2016 and April 2020 will be considered for the study and will be enrolled according to the inclusion/exclusion criteria reported.
You may qualify if:
- Inborn patients, born between 01/01/2012 and 31/12/2020, admitted to the NICU at birth;
- Prenatal diagnosis of CDH;
- Take charge of the mother with CDH fetus at a gestational age below or equal to 30+6 weeks at our Fetal Surgery Center.
You may not qualify if:
- Outborn patients;
- Lack of prenatal diagnosis of CDH;
- Mother with CDH fetus not taken in charge at our Fetal Surgery Center;
- Prenatal or postnatal diagnosis of non-isolated CDH, thus associated with genetic or malformative anomalies known to have an impact on patients' survival;
- Twin pregnancies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Conte L, Amodeo I, De Nunzio G, Raffaeli G, Borzani I, Persico N, Griggio A, Como G, Colnaghi M, Fumagalli M, Cascio D, Cavallaro G. A machine learning approach to predict mortality and neonatal persistent pulmonary hypertension in newborns with congenital diaphragmatic hernia. A retrospective observational cohort study. Eur J Pediatr. 2025 Mar 11;184(4):238. doi: 10.1007/s00431-025-06073-0.
PMID: 40067512DERIVEDConte L, Amodeo I, De Nunzio G, Raffaeli G, Borzani I, Persico N, Griggio A, Como G, Cascio D, Colnaghi M, Mosca F, Cavallaro G. Congenital diaphragmatic hernia: automatic lung and liver MRI segmentation with nnU-Net, reproducibility of pyradiomics features, and a machine learning application for the classification of liver herniation. Eur J Pediatr. 2024 May;183(5):2285-2300. doi: 10.1007/s00431-024-05476-9. Epub 2024 Feb 28.
PMID: 38416256DERIVEDAmodeo I, De Nunzio G, Raffaeli G, Borzani I, Griggio A, Conte L, Macchini F, Condo V, Persico N, Fabietti I, Ghirardello S, Pierro M, Tafuri B, Como G, Cascio D, Colnaghi M, Mosca F, Cavallaro G. A maChine and deep Learning Approach to predict pulmoNary hyperteNsIon in newbornS with congenital diaphragmatic Hernia (CLANNISH): Protocol for a retrospective study. PLoS One. 2021 Nov 9;16(11):e0259724. doi: 10.1371/journal.pone.0259724. eCollection 2021.
PMID: 34752491DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Giacomo Cavallaro, MD, PhD
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 20, 2020
First Posted
October 30, 2020
Study Start
January 1, 2012
Primary Completion
November 1, 2022
Study Completion
December 1, 2022
Last Updated
November 12, 2024
Record last verified: 2024-11